"Please implant a defibrillator in my patient": It's déjà vu all over again

Heart Rhythm

Volumn 9, Issue 1, 2012, Pages 47-48

  Epstein, Andrew E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

CARDIAC RESYNCHRONIZATION THERAPY; COMORBIDITY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DEFIBRILLATOR; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; NOTE; PARKINSON DISEASE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; QRS COMPLEX; SIGNAL AVERAGED ELECTROCARDIOGRAPHY; T WAVE; UREA NITROGEN BLOOD LEVEL;

EID: 84655163799     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2011.09.058     Document Type: Editorial

References (19)

1. D.P. Zipes Implantable cardioverter-defibrillator Lifesaver or a device looking for a disease? Circulation 89 1994 2934 2936
2. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) J Am Coll Cardiol 51 2008 e1 e62
3. E. Erikson Identity: Youth and Crisis 1968 Norton New York, NY
4. Y. Bera Yogi Berra official website http://www.yogiberra.com/yogi-isms. html Accessed September 3, 2011
5. L.W. Stevenson, A.S. Hellkamp, C.V. Leier Changing preferences for survival after hospitalization with advanced heart failure J Am Coll Cardiol 52 2008 1702 1708
6. J.J. Goldberger, M.E. Cain, S.H. Hohnloser American Heart Association/American College of Cardiology/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death Circulation 118 2008 1497 1518
7. G.B. Bleeker, T.A.M. Kaandorp, H.J. Lamb Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy Circulation 113 2006 969 976 (Pubitemid 43879472)
8. A.E. Buxton, K.L. Lee, G.E. Hafley Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease Lessons from the MUSTT study J Am Coll Cardiol 50 2007 1150 1157 (Pubitemid 47375017)
9. I. Goldenberg, A.K. Vyas, W.J. Hall Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction J Am Coll Cardiol 51 2008 288 296
10. D.B. Kramer, P.A. Friedman, L.M. Kallinen Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators Heart Rhythm 9 2012 42 46
11. L.A. Cannizzaro, J.P. Piccini, U.D. Patel, A.F. Hernandez Device therapy in heart failure patients with chronic kidney disease J Am Coll Cardiol 58 2011 889 896
12. R.J. Myerburg, R. Mitrani, A. Interian, A. Castellanos Interpretation of outcomes of antiarrhythmic clinical trials Circulation 97 1998 1514 1521
13. I. Goldenberg, J. Gillepsie, A.J. Moss Long-term benefit of primary prevention with an implantable cardioverter-defibrillator Circulation 122 2010 1265 1271
14. W.T. Abraham, W.G. Fisher, A.L. Smith Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853 (Pubitemid 34603028)
15. B.J. Maron, R.A. Nishimura, W.J. McKenna Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy Circulation 99 1999 2927 2933 (Pubitemid 29258982)
16. S.Y.H. Kim, S. Frank, R. Holloway, C. Zimmerman, R. Wilson, K. Kieburtz Science and ethics of sham surgery A survey of Parkinson disease clinical researchers Arch Neurol 62 2005 1357 1360 (Pubitemid 41352051)
17. A.E. Epstein, A.P. Hallstrom, W.J. Rogers Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST) JAMA 270 1993 2451 2455 (Pubitemid 23342294)
18. L.A. Cobb, G.I. Thomas, D.H. Dillard, K.A. Merendino, R.A. Bruce An evaluation of internal-mammary-artery ligation by a double-blind technic N Engl J Med 260 1959 1115 1118
19. The Coronary Drug Project Research Group The Coronary Drug Project: findings leading to discontinuation of the 25-mg/day estrogen group JAMA 226 1973 652 657